Nuclear medicine
Area of medical practice that uses radioactive medicines to diagnose and treat different health conditions
Procedures:
Services:
A CT scan (computed tomography) of blood vessels of the heart (coronary arteries).
An imaging test using radioactive dye to look at the blood flow to the heart muscle while the heart is beating (gated cardiac blood pool study). Can include one or both of 2D (planar imaging) and 3D scans (single photon emission computed tomography/SPECT).
Imaging tests using radioactive tracers to look at blood flow (perfusion) and air flow (ventilation) in the lungs. Includes one or both of 2D or 3D scans (planar imaging, single photon emission computed tomography/SPECT).
An imaging test using radioactive dye to look at the system in the body that makes bile (hepatobiliary study). Can include a medicine to increase bile flow (cholagogue).
An imaging test using radioactive dye to look at and record the system in the body which makes bile (hepatobiliary study). Includes a medicine to increase bile flow (cholagogue).
An imaging test using radioactive tracer to look for fluid coming back up into the food pipe from the stomach (gastro oesophageal reflux study).
An imaging test using radioactive tracer to measure how quickly food or liquid leaves the stomach (gastric emptying study).
An imaging test using radioactive tracer to measure how quickly food and liquid leaves the stomach (gastric emptying study).
An imaging test using radioactive tracer to look at how the large intestine is working (radionuclide colonic transit study).
An imaging test using radioactive dye to look at the kidneys (renal study). This is to check the blood supply (perfusion) or to look at the outer part of the kidneys (cortical study).
An imaging test using radioactive dye to look at the outer part of the kidneys (renal cortical study). Includes 2D and 3D scans (planar imaging, single photon emission computed tomography/SPECT).
An imaging test using radioactive dye to look at the kidneys (renal study). Includes giving a medicine before the test. A previous renal study has been performed.
An imaging test using radioactive tracer to look at blood flow in certain areas of the brain (cerebral perfusion study). Includes 2D and 3D scans (planar imaging, single photon emission computed tomography/SPECT).
A whole body imaging test using radioactive dye to look at the bones. May include looking at blood flow and the amount of blood in the heart during different parts of the heart beat (blood pool).
A whole body imaging test using radioactive dye to look at the bones. May include looking at blood flow and the amount of blood in the heart during different parts of the heart beat (blood pool). Includes 3D scans (single photon emission computed tomography/SPECT).
An imaging test using a radioactive dye to look at bones or joints. This may also involve looking at blood flow and the amount of blood in the heart during different parts of the heart beat (blood pool). Includes 3D images (single photon emission computed tomography/SPECT).
An imaging test using a radioactive dye to look at the lymphatic system and locate lymph nodes (lymphoscintigraphy).
An imaging test using a radioactive dye to look at a gland in the neck (thyroid).
An imaging test using a radioactive dye to look at a gland in the neck (parathyroid gland). Includes both 2D and 3D scans (planar imaging, single photon emission computed tomography/SPECT).
A CT scan done at the same time as a 3D scan using radioactive dye (single photon emission computed tomography) for a more accurate image of one body area.
A whole body scan (FDG PET study) to learn more about cancer of the breast. This is to see if the cancer might have spread within the breast or to other organs (metastatic).
A whole body scan (FDG PET study) to check for cancer cells related to or spreading from cancer in the large intestine (colorectal carcinoma).
A whole body scan (FDG PET study) to check if skin cancer has returned or spread to other areas of the body (metastatic or recurrent malignant melanoma). This is after a person had treatment.
A scan (FDG PET study) of the brain. This is for a person with epilepsy not controlled with medication (refractory epilepsy).
A whole body scan (FDG PET study) to learn more about cancer of the ovaries. This is to see if the cancer remains at the original site (residual), has spread to other organs (metastatic) or has returned in the original site (recurrent).
A whole body scan (FDG PET study) to learn more about a cancer of the cervix (carcinoma of the uterine cervix). This is before the person has treatment.
A whole body scan (FDG PET study) to learn more about a cancer of the cervix (carcinoma of the uterine cervix) which has returned.
A whole body scan (FDG PET study) to learn more about a cancer of the oesophagus (oesophageal or GEJ carcinoma).
A whole body scan (FDG PET study) to learn more about a newly diagnosed or returning cancer of the head and neck.
A whole body scan (FDG PET study) to look for cancer cells which have spread (metastatic squamous cell carcinoma) from an unknown area into lymph nodes of the neck (cervical nodes).
A whole body scan (FDG PET study) to learn more about a blood cancer (Hodgkin lymphoma, non-Hodgkin lymphoma). The person is newly diagnosed or has not been previously treated.
A whole body scan (FDG PET study) to learn more about a blood cancer (Hodgkin lymphoma, non-Hodgkin lymphoma) which has returned.
Specialist treatment using thyroid stimulating hormone (thyrotropin alfa) for a person who has had their thyroid removed because of cancer.
A procedure using specialised X ray to measure bone strength (densitometry) in two or more different bones. This procedure is done to confirm low bone density after a broken bone or monitor someone already with low bone density.
A procedure using specialised X ray to measure bone strength (densitometry) in two or more different bones. This is to diagnose and monitor bone loss caused by certain medications or medical conditions.
A procedure using specialised X ray to measure bone strength (densitometry) in two or more different bones. This is to diagnose and monitor bone loss caused by certain medical conditions.
A procedure using specialised X ray or CT scans to measure bone strength (densitometry) in two or more different bones. This is for patients aged 70 years and older.
A procedure using specialised X ray to measure bone strength (densitometry) in two or more different bones at least 12 months after a major change in therapy.
A procedure using specialised X ray or CT scans to measure bone strength (densitometry) in two or more different bones. This is for patients aged 70 years and older with low bone density.
A test to check how well the kidneys are working (renal function test).
A test using imaging and also taking two blood samples to check how well the kidneys are working (renal function test).
A follow-up appointment with a consultant physician to review ongoing care for a complex disorder. The appointment is 20 minutes or longer.
A follow-up appointment with a consultant physician. The consultant physician will look at a specific condition and/or provide a course of treatment. The appointment is at their rooms.
The first appointment with a consultant physician to assess and plan care for a complex disorder. The appointment is 45 minutes or longer.
The first appointment with a consultant physician. The consultant physician will look at a specific condition and/or provide a course of treatment. The appointment is at their rooms.
A meeting with a GP or specialist and at least 4 medical professionals and allied health providers. The meeting is to develop a treatment plan for a person with cancer, and is 10 minutes or longer.
A procedure using a needle through the skin to take a sample from an organ deep in the body for testing (percutaneous aspiration biopsy). Imaging is used to help identify where the needle must go.